Sinopia Biosciences, Inc. is a privately held biotechnology company advancing novel therapeutics using its proprietary LEADS® (LEarn And DiScover) drug discovery platform. Sinopia’s LEADS® platform integrates high-throughput omics data, AI/machine learning, and network analyses. Sinopia is advancing multiple first-in-class programs with high unmet need, including its lead program for Parkinson’s disease. Sinopia is headquartered at JLABS in San Diego, California.
Looking for a particular Sinopia Biosciences employee's phone or email?
The Sinopia Biosciences annual revenue was $4 million in 2026.
Iman Famili is the President and CEO of Sinopia Biosciences.
4 people are employed at Sinopia Biosciences.
Sinopia Biosciences is based in San Diego, California.
The NAICS codes for Sinopia Biosciences are [54171, 541714, 5417, 54, 541].
The SIC codes for Sinopia Biosciences are [87, 873].